A Selective Neurokinin-1 Receptor Antagonist in Chronic PTSD: A Randomized, Double-Blind, Placebo-Controlled, Proof-Of-Concept Trial
European Neuropsychopharmacology - Netherlands
doi 10.1016/j.euroneuro.2010.11.012
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2011
Authors
Publisher
Elsevier BV